Search Results for "Sufentanil Alpha Long Half Life"
Original Source: [Baxter Healthcare Corporation]
Sufentanil Citrate Injection, USPCII
Matching Channels
Interleukin 1 IL 1 Receptor IL 1R
Interleukin-1 (IL-1) beta is a proinflammatory cytokine driving joint inflammation as well as systemic signs of inflammation, such as fever and acute phase protein production. Current therapy targetin...
Self-management is quite a new idea in healthcare, and it is for patient with long-term conditions to regain some control over their life, and to be able lead a better life, despite their heal...
Matching News
AcelRx gains on Phase III data for Sufentanil NanoTab System
AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) gained $0.73 (23%) to $3.93 on Thursday after reporting that its Sufentanil NanoTab PCA System met the primary endpoint of non-inferiority to IV patient-contr...
AcelRx Announces Primary Endpoint Met in Phase 3 Non-Inferiority Study of Sublingual Sufentanil ...
- In this open-label study, the Sufentanil NanoTab PCA System also demonstrated statistical superiority to IV PCA morphine for primary endpoint of Patient Global Assessment of method of pain cont...
AcelRx wins US patent for sufentanil NanoTab based products
AcelRx Pharmaceuticals has received a US patent which provides intellectual property protection for sufentanil NanoTab based products through late 2030.
Finding could help Alpha-1 sufferers breathe more easily
Scientists have identified a new mutation in the gene that causes the inherited disease known as Alpha-1 Antitrypsin Deficiency (Alpha-1), which affects roughly one in 2,500 people of European descent...
A finding that could help Alpha-1 sufferers breathe more easily
(Research Australia) Scientists have identified a new mutation in the gene that causes the inherited disease known as Alpha-1 Antitrypsin Deficiency (Alpha-1), which affects roughly one in 2,500 peopl...
COPD Foundation Marks 50th Anniversary of Discovery of Alpha-1 Gene
Washington, D.C. - March 25, 2013 - The COPD Foundation marks the 50th Anniversary of the discovery of the gene for Alpha-1 Antitrypsin Deficiency (Alpha-1), a rare condition that causes genetic emphy...
AcelRx sufentanil NanoTab pain products gain additional US patents
The US Patent and Trademark Office (USPTO) has issued two additional patents to AcelRx Pharmaceuticals' sufentanil NanoTab pain products.
AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil ...
Patients experienced significantly greater reduction in pain as measured by SPID-48 vs. placebo (p=0.001) - Adverse events in sufentanil-treated patients similar to placebo - AcelRx to co...
Matching PubMed Articles
Aspects of pharmacokinetics and pharmacodynamics of sufentanil in pediatric practice.
Sufentanil is a potent synthetic opioid. Like other opioids, sufentanil creates a stable hemodynamic environment in cardiovascularly compromised pediatric patients. Clearance, expressed as per kilogra...
A rapid, selective and highly sensitive ultra-performance liquid-chromatography mass-spectrometry (UPLC-MS/MS) method has been developed and validated for the determination of sufentanil in human plas...
Objective: Sufentanil has been reported to provide stable hemodynamics similar to other opioids. However, it has not been reliably established whether this stability can be attributed only to Sufentan...
A comprehensive LC-MS-based quantitative analysis of fentanyl-like drugs in plasma and urine.
Fentanyl, norfentanyl, alfentanil, sufentanil, remifentanil and 3-methylfentanyl are potent, short-acting, synthetic narcotic analgesics that are not revealed in standard opiate immunoassays. In this...
ABSTRACT: BACKGROUND: Long-lasting insecticidal nets (LLIN) are now standard for the prevention of malaria. However, only products with recommendation for public use from the World Health Organizatio...
